Position paper for health authorities: Archived clinical pathology data – treasure to revalue and appropriate

Résumé

Archived clinical pathology data (ACPD) is recognized as useful for research. Given our privileged deidentified ACPD from South West Pathology Service (SWPS), attempt is made to estimate what it would cost any researcher without such privilege to generate the same data. The Ethics Committee of the Area Health Service approved a request for Dr. Uba Nwose to use de-identified ACPD acquired by the SWPS for clinical laboratory-based translational biomedical science research. 10-years (1999 – 2008) have been pooled to constitute the database. Data include blood sugar, cholesterol, D-dimer, ESR, glucose tolerance, haematocrit, HbA1c, homocysteine, serum creatinine, total protein and vitamins [C & E] amongst others. For this report, the bulk-billed-cost of tests were estimated based on number and unit price of each test performed. AU$17,507,136.85 is the cost paid by Medicare in the period. This amount is a conservative estimate that could be spent to generate such 10-years data in the absence of ACPD. The health/pathology service has not given any financial research grant. However, the support-in-kind is worth more than celebrated competitive research grants. It calls for revaluatrion by academic, research and scientific institutions the use of ACPD. For the countries where such provision is non-existent, this report provides a ‘Position Paper’ to present to the directorates or institutes of health authorities to appropriate the value of ACPD and approve of their use as a research treasure and resource management tool.

Keywords: Archives, clinical laboratory, health authorities, research, resource management

Résumé
L’archive des données cliniques pathologiques (ADCP) est reconnu comme utile en recherche. Etant donné que nos privileges du service pathologique du Sud Ouest (SWPS). Le comite éthique du service de santé était approuve et utilise pour identifier et pour extraire les données cliques pathologiques et les données des tests de laboratoires. Cette étude rétrospective de 10-ans (1999 – 2008) servait comme la base de données. Les données collectées incluent le taux de glucose sanguin, taux de cholestérol, Ddimère, ESR, tolérance en glucose, hématocrite, HbA1c, homocysteine, taux de serum en créatinine, taux des protéines totales et les vitamines [C & E] parmi d’autres. Dans cette étude, le cout total des tests étaient estimes en fonction du nombre et du prix unitaire de chaque test fait. AU$17, 507,136.85 est le cout des soins médicaux en cette période. Cette somme est une estimative conservatrice qui pourrait dépenser pour générer des données de 10 ans en absence de l’ADCP. Le service pathologique en sante n’a jamais donne une assistance financière en recherche. Cependant, Un support moral est valeureux plus que de célébrer la compétition financière en recherche. Une réévaluation est nécessaire par les académiciens, les chercheurs et les institutions scientifiques sur l’usage d’ADCP. Pour les pays ou de telle provision n’existe pas, Cette étude apporte une position a présenter aux autorités et institutions en santé sur la valeur de l’ADCP et d’approuver leur usage comme une banque des données et ressources.

Correspondence: Dr. E.U. Nwose, South West Pathology Service, 590 Smollett St., Albury 2640 NSW, Austrilia. E-mail: ezekiel.nwose@gsahs.health.nsw.gov.au; nwoseeu@hotmial.com

pdf (anglais)

Références

Paterlini M. When in Rome, reform. Radical reform of the Italian research and education systems is needed to address the lack of autonomy and lack of funding. EMBO Rep 2009; 10: 128-131

Nwose EU, Cann N and Jha G. Coagulase-negative Staphylococcus bacteraemia evaluation: lack of clinical information and prevalence of methicillin resistance. Aust J Med Sci 2009; 30: 52-55.

Nwose EU, Bwititi P, Cann N and Butkowski G. Low serum creatinine levels as risk factor of diabetes mellitus: prediabetes considerations [Abstract]. IBMS Congress 2009 September

Nwose EU, Butkowski G and Cann N. Whole blood viscosity determination in diabetes management: perspective in practice. North Am J Med Sci 2009; 1: 110-113

Nwose E, Veneris K, Pearce M, Jha G, Murphy J and Robb D. Chromogenic methicillin-resistant Staphylococcus aureus media: Notice of two types of false positive morphologies. Aust J Med Sc 2008; 29: 50-53.

Mandisodza AR, Charuma H, Masoha A, Musekiwa Z, Mvere D and Abayomi A. Prevalence of HIV infection in school based and other young donors during the 2002 and 2003 period. Afr J Med Med Sci 2006; 35: 69-72

Oyelese AO, Udoh SJ, Zailani SB and Ijaware CO. Pattern of intestinal parasites among hosptial patients at Ile-Ife. Afr J Med Med Sci 2002; 31: 107-109

Sanders R. Mining the Swedish clinical archives to develop pharmacogenomic tests. Mol Diagn 1999; 4: 319-325

Nwose EU, Richards RS, Cann NG and Butkowski E. Cardiovascular risk assessment in prediabetes: a hypothesis. Med Hypotheses 2009; 72: 271-275.

Dowling NF, Beckman MG, Manco-Johnson M, Hassell K, Philipp CS, Michaels LA et al. The U.S. Thrombosis and Hemostasis Centers pilot sites program. J Thromb Thrombolysis 2007; 23: 1-7.

Badrick T. Is there a future for medical scientists and their associations? Aust J Med Sci 2007; 28(1): 3-15

Woods A. Open letter to medical scientists working in diagnostic pathology. Pathology Associations Council 21st December 2009

Dhaliwal G and Sharpe BA. Twelve tips for presenting a clinical problem solving exercise. Med Teach 2009; 31: 1056-1059.

Thacker SB, Koo D and Delany JR. Career paths to public health: programs at the Centers for Disease Control and Prevention. Am J Prev Med 2008; 35: 279-283

Leloux M and Groen A. Estimating business value of academic research outcomes: towards a multi-dimensional approach. IJTTC 2009; 8: 3-21

Benfari MJ and Neuhauser D. Paying for diagnostic accuracy. Health Care Manage Rev 1976; 1: 7-12.